Skip to main content
. 2021 Sep 6;9(9):1170. doi: 10.3390/biomedicines9091170

Table 1.

Sapporo criteria for APS classification.

Clinical and Laboratory Criteria
Vascular thrombosis
  • ≥1 clinical episode of arterial, venous, or small vessel thrombosis.

  • Thrombosis must be objectively confirmed.

  • For histopathological confirmation, thrombosis must be present without inflammation of the vessel wall.

Pregnancy morbidity
  • ≥1 unexplained death of a morphologically normal fetus ≥10 weeks of gestation.

  • ≥1 premature delivery of a morphologically normal fetus <34 weeks of gestation because of.

  • Severe preeclampsia or eclampsia defined according to standard definition.

  • Recognized features of placental insufficiency.

  • ≥3 unexplained consecutive miscarriages < 10 weeks of gestation, with maternal and paternal factors (anatomic, hormonal, or chromosomal abnormalities) excluded.

Laboratory criteria
  • Presence of aPL, on two or more occasions at least 12 weeks apart and no more than 5 years prior to clinical manifestations, as demonstrated by ≥1 of the following.

  • LA.

  • Medium to high-titer (>40 GPL or MPL, or >99th percentile) aCL IgG or IgM.

  • Anti-β2 glycoprotein-I (anti-β2GPI) IgG or IgM > 99th percentile.